AMOT and ovarian carcinoma: Besides, by using reverse‐phase protein array analysis and in vivo RNA antisense purification, Lin X and colleagues62 further identified that UCA1 could bind to a well‐known YAP regulator, angiomotin (AMOT) in ovarian cancer.